Copyright
©The Author(s) 2025.
World J Radiol. Sep 28, 2025; 17(9): 111924
Published online Sep 28, 2025. doi: 10.4329/wjr.v17.i9.111924
Published online Sep 28, 2025. doi: 10.4329/wjr.v17.i9.111924
Table 1 Baseline characteristics, n (%)
Parameter | Before PSM | After PSM | ||||
TFM (n = 113) | non-TFM (n = 377) | P value | TFM (n = 108) | non-TFM (n = 216) | P value | |
Sex | ||||||
Female | 82 (72.6) | 261 (69.2) | 0.497 | 77 (71.3) | 135 (62.5) | 0.148 |
Male | 31 (27.4) | 116 (30.8) | 31 (28.7) | 81 (37.5) | ||
Age (year) | 41.7 ± 10.6 | 41.1 ± 10.7 | 0.996 | 41.5 ± 10.6 | 41.2 ± 10.9 | 0.782 |
FT3 (pg/mL) | 3.1 ± 0.4 | 3.2 ± 0.5 | 0.039 | 3.2 ± 0.4 | 3.2 ± 0.4 | 0.059 |
FT4 (ng/dL) | 1.3 ± 0.2 | 1.3 ± 0.2 | 0.111 | 1.3 ± 0.2 | 1.3 ± 0.2 | 0.234 |
TSH (uIU/mL) | 1.9 ± 1.1 | 2.0 ± 1.2 | 0.972 | 2.0 ± 1.1 | 2.1 ± 1.4 | 0.426 |
Maximum diameter (cm) | ||||||
≤ 1 | 75 (66.4) | 293 (77.7) | 0.014 | 75 (69.4) | 159 (73.6) | 0.511 |
> 1 | 38 (33.6) | 84 (22.3) | 33 (30.6) | 57 (26.4) | ||
Lesion location | ||||||
Left lobe | 55 (48.7) | 179 (47.5) | 0.210 | 52 (48.1) | 109 (50.5) | 0.088 |
Right lobe | 50 (44.2) | 185 (49.1) | 48 (44.4) | 102 (47.2) | ||
Isthmus | 8 (7.1) | 13 (3.4) | 8 (7.4) | 5 (2.3) |
Table 2 Treatment parameters in the thermal field management and non-thermal field management groups
Variables | Before PSM | After PSM | ||||
TFM (n = 113) | non-TFM (n = 377) | P value | TFM (n = 108) | non-TFM (n = 216) | P value | |
Ablation time (second) | 73.0 (18.0-524.0) | 119.0 (17.0-681.0) | < 0.001 | 72 (18-524) | 121 (17-681) | < 0.001 |
Power (Watt) | 30.0 (25.0-60.0) | 35.0 (15.0-50.0) | < 0.001 | 30 (25-60) | 35 (15-45) | < 0.001 |
Total energy (J) | 2200.0 (660.0-27540.0) | 4080.0 (570.0-26760.0) | < 0.001 | 2145.0 (660.0-27540.0) | 4112.5 (570.0-26760.0) | < 0.001 |
Energy/mL (J/mL) | 12019.2 (477.8-84134.6) | 28490.0 (1648.5-338942.3) | < 0.001 | 12497.1 (477.8-84134.6) | 27243.3 (2991.4-288461.5) | < 0.001 |
Table 3 Complications and side effects in the thermal field management and non-thermal field management groups, n (%)
Variables | Before PSM | After PSM | |||||||
TFM (n = 113) | non-TFM (n = 377) | HR (95%CI) | P value | TFM (n = 108) | non-TFM (n = 216) | HR (95%CI) | P value | ||
Complications | Voice change | 1 (0.9) | 23 (6.1) | 0.137 (0.018-0.963) | 0.024 | 1 (0.9) | 14 (6.5) | 0.135 (0.017-0.983) | 0.049 |
Vomiting | 0 (0.0) | 1 (0.3) | - | 1.000 | 0 (0) | 0 (0) | - | - | |
Side effect | Pain | 4 (3.5) | 35 (9.3) | 0.359 (0.125-0.987) | 0.048 | 4 (3.7) | 21 (9.7) | 0.357 (0.119-1.068) | 0.090 |
Neck discomfort | 2 (1.8) | 10 (2.7) | 0.661 (0.143-3.063) | 0.594 | 2 (1.9) | 6 (2.8) | 0.660 (0.131-3.328) | 0.899 | |
Coughing | 0 (0.0) | 2 (0.5) | - | 1.000 | 0 (0) | 1 (0.5) | - | 1.000 | |
Dry mouth | 4 (3.5) | 26 (6.9) | 0.495 (0.169-1.451) | 0.192 | 4 (3.7) | 14 (6.5) | 0.555 (0.1789-1.728) | 0.440 | |
Dysphagia | 0 (0.0) | 3 (0.8) | - | 1.000 | 0 (0) | 3 (1.4) | - | 0.538 | |
Foreign body sensation | 1 (0.9) | 8 (2.1) | 0.412 (0.051-3.328) | 0.692 | 1 (0.9) | 4 (1.9) | 0.495 (0.055-4.486) | 0.873 | |
Tachycardiac | 3 (2.7) | 10 (2.7) | 1.001 (0.271-3.701) | 0.999 | 3 (2.8) | 6 (2.8) | 1.000 (0.245-4.078) | 1.000 | |
Tired | 6 (5.3) | 27 (7.2) | 0.727 (0.292-1.807) | 0.491 | 6 (5.6) | 17 (7.9) | 0.689 (0.263-1.800) | 0.592 |
- Citation: Cai WJ, Li Y, Wei Y, Zhao ZL, Wu J, Cao SL, Peng LL, Li SQ, Yu MA. Thermal field management improves patient-reported outcomes during ablation for papillary thyroid carcinoma: A retrospective cohort study. World J Radiol 2025; 17(9): 111924
- URL: https://www.wjgnet.com/1949-8470/full/v17/i9/111924.htm
- DOI: https://dx.doi.org/10.4329/wjr.v17.i9.111924